127 related articles for article (PubMed ID: 4705154)
1. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
Young RC; Walker MD; Canellos GP; Schein PS; Chabner BA; DeVita VT
Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
[No Abstract] [Full Text] [Related]
2. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
Gailani S; Kutcher J
J Med; 1973; 4(4):209-18. PubMed ID: 4520348
[No Abstract] [Full Text] [Related]
3. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Brunner KW; Maurice P; Sonntag RW
Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
[No Abstract] [Full Text] [Related]
4. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
Lokich JJ; Skarin AT; Frei E
Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
[No Abstract] [Full Text] [Related]
5. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
Klaassen DJ; Rapp E
Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
[No Abstract] [Full Text] [Related]
6. Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.
Sponzo RW; DeVita VT; Oliverio VT
Cancer; 1973 May; 31(5):1154-6. PubMed ID: 4705152
[No Abstract] [Full Text] [Related]
7. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
Broder LE; Hansen HH
Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
[No Abstract] [Full Text] [Related]
8. Treatment of malignant melanoma with methyl CCNU.
Young RC; Canellos GP; Chabner BA; Schein PS; Brereton HD; DeVita VT
Clin Pharmacol Ther; 1974 Jun; 15(6):617-22. PubMed ID: 4601745
[No Abstract] [Full Text] [Related]
9. Lomustine treatment of metastatic renal cell carcinoma.
Mittelman A; Albert DJ; Murphy GP
JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
[No Abstract] [Full Text] [Related]
10. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
[No Abstract] [Full Text] [Related]
11. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
[No Abstract] [Full Text] [Related]
12. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
Giles GR; Hall R; Brennan TG; Worthy TS
Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
[No Abstract] [Full Text] [Related]
13. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
[TBL] [Abstract][Full Text] [Related]
14. Comparative toxicity on leukocytes and platelets of two regimens of CCNU: the relationship between maximum dose and optimum dose.
Israel L; Chahinian P
Eur J Cancer (1965); 1973; 9(11-12):799-802. PubMed ID: 4374357
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
Einhorn LH; Livingston RB; Gottlieb JA
Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
[No Abstract] [Full Text] [Related]
16. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
[No Abstract] [Full Text] [Related]
17. Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).
DeConti RC; Hubbard SP; Pinch P; Bertino JR
Cancer Chemother Rep; 1973 Apr; 57(2):201-7. PubMed ID: 4742499
[No Abstract] [Full Text] [Related]
18. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.
Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
Eur J Cancer (1965); 1973 Sep; 9(9):627-34. PubMed ID: 4803230
[No Abstract] [Full Text] [Related]
20. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
Gottlieb JA; Rivkin SE; Spigel SC; Hoogstraten B; O'Bryan RM; Delaney FC; Singhakowinta A
Cancer; 1974 Feb; 33(2):519-26. PubMed ID: 4812769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
